BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rajagopalan G, Tilahun AY, Asmann YW, David CS. Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor. Physiol Genomics 2009;37:279-93. [PMID: 19336531 DOI: 10.1152/physiolgenomics.90385.2008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Tilahun AY, Marietta EV, Wu TT, Patel R, David CS, Rajagopalan G. Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome. Am J Pathol 2011;178:2760-73. [PMID: 21641398 DOI: 10.1016/j.ajpath.2011.02.033] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
2 Tuffs SW, Haeryfar SMM, McCormick JK. Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens. Pathogens 2018;7:E53. [PMID: 29843476 DOI: 10.3390/pathogens7020053] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 10.8] [Reference Citation Analysis]
3 Kale SD, Mehrkens BN, Stegman MM, Kastelberg B, Carnes H, McNeill RJ, Rizzo A, Karyala SV, Coutermarsh-Ott S, Fretz JA, Sun Y, Koff JL, Rajagopalan G. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor. Front Immunol 2020;11:1311. [PMID: 32676080 DOI: 10.3389/fimmu.2020.01311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hudson Reichenberg LC, Garg R, Fernalld R, Bost KL, Piller KJ. Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B. Toxicon 2017;133:82-90. [PMID: 28478060 DOI: 10.1016/j.toxicon.2017.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Xu SX, Gilmore KJ, Szabo PA, Zeppa JJ, Baroja ML, Haeryfar SM, McCormick JK. Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect Immun 2014;82:3588-98. [PMID: 24914221 DOI: 10.1128/IAI.02110-14] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
6 Tilahun AY, Karau M, Ballard A, Gunaratna MP, Thapa A, David CS, Patel R, Rajagopalan G. The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia. Mediators Inflamm 2014;2014:468285. [PMID: 25024509 DOI: 10.1155/2014/468285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
7 Tilahun AY, Holz M, Wu TT, David CS, Rajagopalan G. Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One 2011;6:e16764. [PMID: 21304813 DOI: 10.1371/journal.pone.0016764] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
8 Mujtaba MG, Johnson HM, Parrish JM. Staphylococcal Enterotoxin Superantigens Induce Prophylactic Antiviral Activity Against Encephalomyocarditis Virus In Vivo and In Vitro. Viral Immunol 2021;34:392-400. [PMID: 33566741 DOI: 10.1089/vim.2020.0310] [Reference Citation Analysis]
9 Gu L, Yue J, Zheng Y, Zheng X, Wang J, Wang Y, Li J, Jiang Y, Jiang H. Evaluation of a recombinant double mutant of staphylococcal enterotoxin B (SEB-H32Q/K173E) with enhanced antitumor activity effects and decreased pyrexia. PLoS One 2013;8:e55892. [PMID: 23405232 DOI: 10.1371/journal.pone.0055892] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Accardo Palumbo A, Forte G, Pileri D, Vaccarino L, Conte F, D’amelio L, Palmeri M, Triolo A, D’arpa N, Scola L, Misiano G, Milano S, Lio D. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns 2012;38:208-13. [DOI: 10.1016/j.burns.2011.07.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
11 Tilahun AY, Theuer JE, Patel R, David CS, Rajagopalan G. Detrimental effect of the proteasome inhibitor, bortezomib in bacterial superantigen- and lipopolysaccharide-induced systemic inflammation. Mol Ther 2010;18:1143-54. [PMID: 20372109 DOI: 10.1038/mt.2010.53] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
12 Schnell FJ, Sundholm S, Crumley S, Iversen PL, Mourich DV. Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease. PLoS Pathog 2012;8:e1003073. [PMID: 23300439 DOI: 10.1371/journal.ppat.1003073] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
13 Lindsay CD, Griffiths GD. Addressing bioterrorism concerns: options for investigating the mechanism of action of Staphylococcus aureus enterotoxin B. Hum Exp Toxicol 2013;32:606-19. [PMID: 23023027 DOI: 10.1177/0960327112458941] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]